良性子宫切除术围手术期阿片类药物配发与持续性使用:系统综述与Meta分析
该系统综述与Meta分析纳入8项研究共377,569例子宫良性切除术患者,评估围手术期阿片类药物配发剂量及持续性使用预测因素。围手术期83%(95%CI 81-84)患者获配阿片类药物,平均配发143.5吗啡毫克当量(95%CI 40-247);阴道子宫切除术配发量显著低于腹腔镜或开腹子宫切除术。术后持续性阿片类使用率为5%(95%CI 2-8),年轻、吸烟史、饮酒、背痛及纤维肌痛与更高风险显著相关,而手术路径及操作复杂度无显著影响。
要点
- 良性子宫切除术围手术期83%患者获配阿片类药物,平均143.5吗啡毫克当量。
- 阴道子宫切除术配发阿片量显著低于腹腔镜或开腹子宫切除术。
- 术后持续性阿片使用率5%,年轻、吸烟、饮酒、背痛、纤维肌痛为显著预测因素。
核心结论
- 围手术期阿片类药物配发量显著取决于子宫切除术路径,阴道子宫切除术配发吗啡毫克当量最低,开腹子宫切除术最高;但手术路径不显著预测术后持续性阿片使用,而年轻年龄、吸烟、饮酒、背痛及纤维肌痛与持续性使用显著相关。
研究设计与样本
- 系统综述与Meta分析,检索PubMed、Web of Science及Embase自建库至2022年3月25日,纳入8项报告良性子宫切除术患者阿片配发数据的研究,共377,569名女性,采用随机效应模型合并均数差或比值比及95%置信区间。
主要发现
- 围手术期83%(95%CI 81-84)女性获配阿片类药物,平均配发量为143.5吗啡毫克当量(95%CI 40-247)。
- 阴道子宫切除术配发阿片量显著低于腹腔镜或开腹子宫切除术。
- 良性子宫切除术后总体持续性阿片使用率为5%(95%CI 2-8)。
- 年轻年龄(OR 1.38;95%CI 1.17-1.63)、吸烟史(OR 1.87;95%CI 1.67-2.10)、饮酒(OR 3.16;95%CI 2.34-4.27)、背痛(OR 1.50;95%CI 1.10-2.05)及纤维肌痛(OR 1.60;95%CI 1.39-1.83)与持续性阿片使用风险升高显著相关。
- 子宫切除术路径及操作复杂度对术后持续性阿片使用无显著影响。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This meta-analysis was conducted to (1) assess the quantity and dose of perioperatively dispensed opioids for benign hysterectomy by procedure route and (2) identify the predictors of persistent opioid use after the procedure. DATA SOURCES: PubMed, Web of Science, and Embase were systematically searched from study inception to 25 March 2022. STUDY ELIGIBILITY CRITERIA: Studies reporting data on opioid dispensing among patients undergoing benign hysterectomy were considered eligible. The primary outcome was the dosage of opioids dispensed perioperatively (from 30 preoperative days to 21 postoperative days). The secondary outcome was the predictors of persistent opioid use after benign hysterectomy (from 3 months to 3 years postoperatively). Total opioid dispensing was measured in morphine milligram equivalents units. METHODS: The random-effects model was used to pool the mean differences or odds ratios and the corresponding 95% confidence intervals. RESULTS: A total of 8 studies presenting data on 377,569 women undergoing benign hysterectomy were included. Of these women, 83% (95% confidence interval, 81-84) were dispensed opioids during the perioperative period. The average amount of perioperatively dispensed opioids was 143.5 morphine milligram equivalents (95% confidence interval, 40-247). Women undergoing vaginal hysterectomy were dispensed a significantly lower amount of opioids than those undergoing laparoscopic or abdominal hysterectomies. The overall rate of persistent opioid use after benign hysterectomy was 5% (95% confidence interval, 2-8). Younger patient age (odds ratio, 1.38; 95% confidence interval, 1.17-1.63), smoking history (odds ratio, 1.87; 95% confidence interval, 1.67-2.10), alcohol use (odds ratio, 3.16; 95% confidence interval, 2.34-4.27), back pain (odds ratio, 1.50; 95% confidence interval, 1.10-2.05), and fibromyalgia (odds ratio, 1.60; 95% confidence interval, 1.39-1.83) were significantly associated with a higher risk of persistent opioid use after benign hysterectomy. However, there was no significant effect of hysterectomy route and operative complexity on persistent opioid use postoperatively. CONCLUSION: Perioperative opioid dispensing was significantly dependent on the route of hysterectomy, with the lowest dispensed morphine milligram equivalents of opioids for vaginal hysterectomy and the highest for abdominal hysterectomy. Nevertheless, hysterectomy route did not significantly predict persistent opioid use postoperatively, whereas younger age, smoking, alcohol use, back pain, and fibromyalgia were significantly associated with persistent opioid use.
引用
- Hessami K, Welch J, Frost A, et al. Perioperative opioid dispensing and persistent use after benign hysterectomy: a systematic review and meta-analysis. Am J Obstet Gynecol. 2022. PMID: 36539027. doi:10.1016/j.ajog.2022.12.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。